Generalized Anxiety Disorder
8 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| App AURORA (Digital Therapy) + conventional treatment for generalized anxiety disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Crisugabalin for generalized anxiety disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ITI-1284 10 mg for generalized anxiety disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ITI-1284 20 mg for generalized anxiety disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lysergide d-tartrate for generalized anxiety disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Mindfulness-Based Stress Reduction for generalized anxiety disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for generalized anxiety disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Venlafaxine for generalized anxiety disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |